T1	SNP 0 21	Polymorphic variation
T2	Entity 29 39	-202 locus
T3	Entity 43 49	IGFBP3
R1	SNP_location Arg1:T1 Arg2:T2	
R2	SNP_coupled_gene Arg1:T1 Arg2:T3	
T4	Organic_inorganic_molecules_affected 64 76	serum levels
E1	Organic_inorganic_molecules_affected:T4 Theme:T5 Agent:T1
T5	Entity 80 107	insulin-like growth factors
T6	Association 173 177	risk
E2	Association:T6 bc:T7 snp_int:T1
T7	Cancer 159 172	breast cancer
T8	Organic_inorganic_molecules_affected 109 120	interaction
E3	Organic_inorganic_molecules_affected:T8 Theme:T9 Theme2:T10 Agent:T1
T9	Entity 126 140	plasma retinol
T10	Entity 145 154	vitamin D
T11	SNP 345 348	SNP
T12	SNP 313 343	single nucleotide polymorphism
R3	Equiv Arg1:T11 Arg2:T12	
T13	Entity 357 365	promoter
T14	Entity 376 383	IGFBP-3
T15	Entity 396 400	-202
R4	SNP_location Arg1:T11 Arg2:T13	
R5	SNP_coupled_gene Arg1:T11 Arg2:T14	
R6	SNP_location Arg1:T11 Arg2:T15	
T16	Gene_Regulation 425 438	transcription
E4	Gene_Regulation:T16 Theme:T14 Agent:T11
T17	Entity 278 291	premenopausal
T18	Cancer 292 305	breast cancer
R7	Risk_Factor Arg1:T11 Arg2:T17	
T19	Association 270 274	risk
E5	Association:T19 bc:T18 snp_int:T11
T20	Entity 1019 1030	AA genotype
T21	Entity 1120 1128	C allele
T22	Level 1883 1886;1901 1912	not significant
T23	Association 1913 1922	influence
E6	Association:T23 snp_int:T24 bc:T25
A1	Level E6 Low
R8	Level_marker Arg1:E6 Arg2:T22	
T24	SNP 1926 1930	this
T25	Cancer 1940 1953	breast cancer
T26	Cancer 1502 1515	Breast cancer
R9	Equiv Arg1:T24 Arg2:T40	
T27	SNP 345 348	SNP
T28	SNP 345 348	SNP
T29	Spec 202 211	suggested
R10	Speculation_marker Arg1:E5 Arg2:T29	
T30	Level 1525 1542	not significantly
T31	Association 1543 1550	related
E7	Association:T31 bc:T26 snp_int:T40
R11	Level_marker Arg1:E7 Arg2:T30	
A2	Level E7 Low
R12	Genotype Arg1:T27 Arg2:T20	
T32	Entity 933 936	Age
R13	Risk_Factor Arg1:T27 Arg2:T32	
T33	Effect_Type 983 990	highest
T34	Organic_inorganic_molecules_affected 946 962;971 977	mean circulating levels
E8	Organic_inorganic_molecules_affected:T34 Theme:T35 Agent:T27
T35	Entity 963 970	IGFBP-3
A3	Effect_Type E8 Increase
R14	Effect_type_marker Arg1:E8 Arg2:T33	
T36	Effect_Type 1035 1044	decreased
T37	Level 1045 1058	significantly
T38	Organic_inorganic_molecules_affected 946 962;971 977	mean circulating levels
E9	Organic_inorganic_molecules_affected:T38 Theme:T35 Agent:T28
R15	Effect_type_marker Arg1:E9 Arg2:T36	
R16	Level_marker Arg1:E9 Arg2:T37	
R17	SNP_allele Arg1:T28 Arg2:T21	
R18	Risk_Factor Arg1:T28 Arg2:T32	
A4	Effect_Type E9 Decrease
A5	Level E9 High
T39	Organic_inorganic_molecules_affected 1683 1695	serum levels
E10	Organic_inorganic_molecules_affected:T39 Agent:T40 Theme:T43
T40	SNP 1658 1670	polymorphism
T41	Entity 1651 1657	IGFBP3
T42	Entity 1646 1650	-202
R19	SNP_coupled_gene Arg1:T40 Arg2:T41	
R20	SNP_location Arg1:T40 Arg2:T42	
T43	Entity 1675 1682	IGFBP-3
